Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 44656 AL 44670

Rehabilitation of Women with Neurodegenerative Diseases

Markos S, Galibov M.

Phys Med Rehabil Clin N Am. 2025 May;36(2):389-398. doi: 10.1016/j.pmr.2024.11.006. Epub 2024 Dec 10.

S-acylation and neuroinflammation: the therapeutic potential of zDHHC and deacylase modulation

Duarte TA, Ng CP, Salvador JAR, Pipito L, Greaves J, Moreira VM.

Eur J Med Chem. 2026 Feb 5;303:118429. doi: 10.1016/j.ejmech.2025.118429. Epub 2025 Nov 29.

Oligonucleotide-based therapeutics for neurodegenerative disorders: Focus on antisense oligonucleotides

Mansour HM, El-Khatib AS.

Eur J Pharmacol. 2025 Jul 5;998:177529. doi: 10.1016/j.ejphar.2025.177529. Epub 2025 Mar 19.

Mitochondrial-Derived Peptides: Implication in the Therapy of Neurodegenerative Diseases

Thakur R, Chauhan A, Moudgil H, Singh S, Devi R.

Mol Neurobiol. 2025 Dec;62(12):15871-15884. doi: 10.1007/s12035-025-05198-5. Epub 2025 Jul 26.

NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies

Zhang K, Wen M, Nan X, Zhao S, Li H, Ai Y, Zhu H.

Front Aging Neurosci. 2025 Jul 24;17:1604378. doi: 10.3389/fnagi.2025.1604378. eCollection 2025.

Overview of Metformin and Neurodegeneration: A Comprehensive Review

Kruczkowska W, Gałęziewska J, Buczek P, Płuciennik E, Kciuk M, Śliwińska A.

Pharmaceuticals (Basel). 2025 Mar 28;18(4):486. doi: 10.3390/ph18040486.

Intersection of H(2)S and Nrf2 signaling: Therapeutic opportunities for neurodegenerative diseases

Soni P, Paswan S, Paul BD, Thomas B.

Neurotherapeutics. 2025 Oct;22(6):e00627. doi: 10.1016/j.neurot.2025.e00627. Epub 2025 Jun 21.

Copper homeostasis and cuproptosis: implications for neurodegenerative diseases

Tao F, Lin M, Meng X, Huang L, Zhuo B, Jiang S, Deng S, Meng Z, Shi J.

Front Aging Neurosci. 2025 Oct 13;17:1688554. doi: 10.3389/fnagi.2025.1688554. eCollection 2025.

CCR5 as a key modulator in neurocognitive disorders

Aung CTZ, Abuaqel K, Zhou M.

Exp Neurol. 2025 Dec;394:115450. doi: 10.1016/j.expneurol.2025.115450. Epub 2025 Aug 28.

Microglial immune memory in Parkinson's and Huntington's diseases: epigenetics, triggers, and therapies

Chowdhury R, Hendlinger A, Riess O, Schulze-Hentrich J.

Epigenomics. 2025 Aug;17(11):739-751. doi: 10.1080/17501911.2025.2518909. Epub 2025 Jul 1.

Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases

Meanti R, Bresciani E, Rizzi L, Molteni L, Coco S, Omeljaniuk RJ, Torsello A.

Biomed Pharmacother. 2025 May;186:118044. doi: 10.1016/j.biopha.2025.118044. Epub 2025 Apr 9.

Mesenchymal Stem Cell-Derived Extracellular Vesicles: Emerging Therapies for Neurodegenerative Diseases

Chen P, Wang F, Ling B, Zhu Y, Lin H, Huang J, Wang X.

Int J Nanomedicine. 2025 Jul 2;20:8547-8565. doi: 10.2147/IJN.S526945. eCollection 2025.

Valbenazine for the treatment of chorea associated with Huntington's disease

Patino J, Furr Stimming E, Testa CM, Mehanna R.

Expert Opin Pharmacother. 2025 Feb;26(2):127-132. doi: 10.1080/14656566.2024.2445728. Epub 2024 Dec 30.

Common alterations to astrocytes across neurodegenerative disorders

Derevyanko A, Tao T, Allen NJ.

Curr Opin Neurobiol. 2025 Feb;90:102970. doi: 10.1016/j.conb.2025.102970. Epub 2025 Jan 28.

Adenosine Receptors in Neuroinflammation and Neurodegeneration

Salmaso V, Menin S, Moro S, Spalluto G, Federico S.

Cells. 2025 Oct 11;14(20):1585. doi: 10.3390/cells14201585.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias